BW
ABBV icon

Bravera Wealth’s AbbVie ABBV Stock Holding History

Bravera Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$616K Hold
2,446
– – 0.24% 51
2026
Q1 		$532K Sell
2,446
-12
-0.5% -$2.66K 0.24% 55
2025
Q4 		$562K Buy
+2,458
New +$560K 0.28% 46

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Bravera Wealth's ABBV Position: Q2 2026 in Review

Bravera Wealth held its AbbVie (ABBV) position steady in Q2 2026 at 2,446 shares worth $616K. The position accounts for 0.24% of the portfolio, ranked #51.

Bravera Wealth first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bravera Wealth held 2,446 shares of AbbVie worth $616K as of Q2 2026.
  • Bravera Wealth left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.24% of Bravera Wealth's portfolio in Q2 2026, its #51 holding.
  • Bravera Wealth first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bravera Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.